Division of Gastroenterology and Hepatology, University of Maryland School of Medicine, Baltimore, United States.
Division of Gastroenterology and Hepatology, Emory University School of Medicine, Atlanta, United States.
Endoscopy. 2024 Aug;56(8):605-611. doi: 10.1055/a-2284-7334. Epub 2024 Mar 22.
Closure of gastrointestinal defects can reduce postprocedural adverse events. Over-the-scope clips and an over-the-scope suturing system are widely available, yet their use may be limited by defect size, location, operator skill level, and need to reinsert the endoscope with the device attached. The introduction of a through-the-scope helix tack suture system (TTSS) allows for closure of large irregular defects using a gastroscope or colonoscope, without the need for endoscope withdrawal. Since its approval 3 years ago, only a handful of studies have explored outcomes using this novel device.
Multiple databases were searched for studies looking at TTSS closure from inception until August 2023. The primary outcomes were the success of TTSS alone and TTSS with clips for complete defect closure. Secondary outcomes included complete closure based on procedure type (endoscopic mucosal resection [EMR], endoscopic submucosal dissection [ESD]) and adverse events.
Eight studies met the inclusion criteria (449 patients, mean defect size 34.3 mm). Complete defect closure rates for TTSS alone and TTSS with adjunctive clips were 77.2% (95%CI 66.4-85.3; I2=79%) and 95.2% (95%CI 90.3-97.7; I2=42.5%), respectively. Complete defect closure rates for EMR and ESD were 99.2% (95%CI 94.3-99.9; I2 = 0%) and 92.1% (95%CI 85-96; I2=0%), respectively. The adverse event rate was 5.4% (95%CI 2.7-10.3; I2=55%).
TTSS is a novel device for closure of postprocedural defects, with relatively high technical and clinical success rates. Comparative studies of closure devices are needed.
胃肠道缺损的闭合可以减少术后不良事件。过内镜夹和过内镜缝合系统已广泛应用,但它们的使用可能受到缺损大小、位置、操作人员技能水平以及需要将带有器械的内镜重新插入的限制。引入经内镜螺旋缝合钉系统(TTSS)允许使用胃镜或结肠镜闭合大的不规则缺损,而无需内镜退出。自 3 年前获得批准以来,只有少数研究探索了使用这种新型器械的结果。
多个数据库被搜索以寻找从成立到 2023 年 8 月期间使用 TTSS 闭合的研究。主要结局是 TTSS 单独和 TTSS 联合夹闭完全闭合的成功率。次要结局包括根据手术类型(内镜黏膜切除术[EMR]、内镜黏膜下剥离术[ESD])和不良事件的完全闭合率。
八项研究符合纳入标准(449 例患者,平均缺损大小 34.3mm)。TTSS 单独和 TTSS 联合夹闭的完全闭合率分别为 77.2%(95%CI 66.4-85.3;I2=79%)和 95.2%(95%CI 90.3-97.7;I2=42.5%)。EMR 和 ESD 的完全闭合率分别为 99.2%(95%CI 94.3-99.9;I2=0%)和 92.1%(95%CI 85-96;I2=0%)。不良事件发生率为 5.4%(95%CI 2.7-10.3;I2=55%)。
TTSS 是一种用于闭合术后缺损的新型器械,具有较高的技术和临床成功率。需要对闭合器械进行比较研究。